ADVERTISEMENT
Prophylactic Tocilizumab Before Anti-CD19 CAR-T Therapy for R/R Lymphoma
12/09/2020
Paolo Caimi, MD, Case Western Reserve University, discusses findings from a study examining the use of prophylactic tocilizumab prior to infusion of anti-CD19 CAR-T cells in patients with relapsed/refractory lymphoma.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Visit the OLN Excellence Forums
Advertisement
Advertisement
Advertisement